← All Sponsors
SPONSOR

Intergroupe Francophone de Cancerologie Thoracique

Total Trials
1
Recruiting
1
Phases
Phase 2
Conditions studied: Pleural Mesotheliomas
NCT06840834 Phase 2
Recruiting

Evaluating Ivonescimab as a Potential Treatment for Pleural Mesothelioma Patients Whose Cancer Has Returned After Previous Immunotherapy and Chemotherapy

Pleural Mesotheliomas
France View Trial →